Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis

Affiliations

• ¹ Hematology Department, Hospital Clínico, Valencia, Spain.
• ² Transfusion Service, Hospital Clínic, Barcelona, Spain.
• ³ Hematology Department, Hospital Clínic, Barcelona, Spain.
• ⁴ Hematology Department, Hospital del Mar, Barcelona, Spain.
• ⁵ Hematology and Medical Oncology Department, Hospital Morales Meseguer, Murcia, Spain.
• ⁶ Hematology Department, Hospital Universitario de Canarias, Tenerife, Spain.
• ⁷ Hematology Department, Hospital 12 de Octubre, Madrid, Spain.
• ⁸ Hematology Department, Hospital Clínico, Santiago de Compostela, Spain.
• ⁹ Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain.
• ¹⁰ Hematology Department, Hospital Duran i Reynals, Hospitalet de Llobregat, Spain.
• ¹¹ Hematology Department, Hospital Vall d'Hebron, Barcelona, Spain.
• ¹² Hematology Department, Hospital Ramón y Cajal, Madrid, Spain.
• ¹³ Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
• ¹⁴ Hematology Department, Hospital La Paz, Madrid, Spain.
• ¹⁵ Hematology Department, Hospital Universitario de Burgos, Burgos, Spain.
• ¹⁶ Hematology Department, Hospital Son Espases, Mallorca, Spain.
• ¹⁷ Hematology Department, Hospital de Jerez, Cádiz, Spain.
• ¹⁸ Hematology Department, Hospital Dr Negrín, Las Palmas de Gran Canaria, Spain.
• ¹⁹ Hematology Department, Hospital Costa del Sol, Marbella, Spain.
• ²⁰ Hematology Department, Hospital La Fe, Valencia, Spain.
• ²¹ Hematology Department, Hospital Sant Pau, Barcelona, Spain.